SolarEdge Stock Pops on Reported Analyst Double Upgrade
SolarEdge Technologies shares popped 20% Tuesday after analysts at Goldman Sachs reportedly issued a double upgrade for the solar equipment maker.
Australia Is New Bond Market Favorite for JPMorgan Asset Management
(Bloomberg) -- The great run in European government bonds is coming to an end, according to a portfolio manager at J.P. Morgan Asset Management, who is now betting Australia will be the next market to outperform.Most Read from BloombergHow California Sees the World, and ItselfLondon’s Tube Fares Are Set to Rise by 4.6% Next YearKim Crawford said there is little room for further gains in Europe compared to peers given swap markets are fairly pricing the amount of interest-rate cuts the European C
Fed Rate Cut Guidance Will Exceed Wall Street’s Bearish Outlook
The cost of borrowing money will likely continue to drop, underpinning riskier assets like bitcoin, says Scott Garliss.
Watch These Nvidia Price Levels as Stock Slips Further Into Correction Territory
Shares Down 15% From Their November High
Trump Serious About Bitcoin Reserve, Says MicroStrategy's Michael Saylor: 'Buy It Now And Own The Future'
MicroStrategy co-founder and executive chairman Michael Saylor said Monday that the incoming Donald Trump administration was serious about setting up a U.S. strategic Bitcoin (CRYPTO: BTC) reserve. What happened: During a CNBC interview, Saylor stressed the importance of "buying the future" if one knows where the money is going. "All the capital outside the U.S. and all the 20th-century antiquated capital is going to flow into digital assets and the Bitcoin network," the Bitcoin bull said. "The
Equities Fall Intraday as Markets Weigh Macro Data
US benchmark equity indexes were lower intraday as the Federal Reserve kicked off its two-day moneta
Housing market outlook: 14 forecasts for mortgage rates in 2025
‘ResiClub’ compiled both public and private mortgage rate forecasts for the end of 2025. Here’s where they predict rates will go.
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
Cantor initiated coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company with five commercialized products. The company also collaborates with pharmaceutical companies to bring new molecules to market using its technologies, like PharmFilm. Aquestive is advancing a late-stage proprietary product candidate for severe allergic reactions, including anaphylaxis, and an earlier-stage epinephrine prodrug topical gel for various dermatology conditions. Cantor highlights that th
Next U.S. Senate Banking Chair Calls Crypto 'Next Wonder' of World
Senator Tim Scott said the Senate will tackle crypto bills, and the incoming chair of the House Financial Services Committee said he hopes to pass them in 2025.